TickerFacts.

Nu Skin Enterprises, Inc. (NUS): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$118.02M
Year ended 2025-12-31
$39.60M
Trailing 12 months to 2026-06-30
-13.7%
3-year compound annual growth
-18.7%
5-year compound annual growth
-9.4%
10-year compound annual growth
$589.03M2008-12-31: $155.82M2009-12-31: $176.27M2010-12-31: $246.68M2011-12-31: $266.59M2012-12-31: $374.26M2013-12-31: $589.03M2014-12-31: $407.11M2015-12-31: $316.07M2016-12-31: $303.50M2017-12-31: $346.05M2018-12-31: $323.86M2019-12-31: $344.08M2020-12-31: $331.56M2021-12-31: $310.31M2022-12-31: $183.35M2023-12-31: $119.19M2024-12-31: -$81.78M2025-12-31: $118.02M$118.02M
2008-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$118.02Mn/m2026-02-13, From 2025-01-01
2024-12-31-$81.78Mn/m2026-02-13, From 2024-01-01
2023-12-31$119.19M-35.0%2026-02-13, From 2023-01-01
2022-12-31$183.35M-40.9%2025-02-14, From 2022-01-01
2021-12-31$310.31M-6.4%2024-02-15, From 2021-01-01
2020-12-31$331.56M-3.6%2023-02-16, From 2020-01-01
2019-12-31$344.08M+6.2%2022-02-16, From 2019-01-01
2018-12-31$323.86M-6.4%2021-02-11, From 2018-01-01
2017-12-31$346.05M+14.0%2020-02-13, From 2017-01-01
2016-12-31$303.50M-4.0%2019-02-14, From 2016-01-01
2015-12-31$316.07M-22.4%2018-02-16, From 2015-01-01
2014-12-31$407.11M-30.9%2017-02-27, From 2014-01-01
2013-12-31$589.03M+57.4%2016-02-18, From 2013-01-01
2012-12-31$374.26M+40.4%2015-03-02, From 2012-01-01
2011-12-31$266.59M+8.1%2014-03-18, From 2011-01-01
2010-12-31$246.68M+39.9%2013-02-27, From 2010-01-01
2009-12-31$176.27M+13.1%2012-02-28, From 2009-01-01
2008-12-31$155.82Mn/a2011-02-23, From 2008-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Nu Skin Enterprises, Inc. (NUS)2025-12-31$118.02Mn/m
Herbalife Ltd. (HLF)2025-12-31$602.20M+18.7%
Cosmos Health Inc. (COSM)2025-12-31-$15.33Mn/m
DataMeds AI, Inc. (MEDS)2025-12-31-$90.54Mn/m
Cardinal Health Inc (CAH)2026-06-30$3.57B+16.4%
Cencora, Inc. (COR)2025-09-30$3.68B+12.6%
McKesson Corp (MCK)2026-03-31$6.94B+37.2%
Stemtech Corp (STEK)2025-12-31-$2.54Mn/m

Compare NUS, HLF, COSM, MEDS side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗